Companies / Aura Biosciences, Inc.

Aura Biosciences, Inc.

Nasdaq: AURACIK 1501796BOSTON, MA

Financials

Revenue—
Net income$-106.19M
Total debt—
Cash$67.84M
Diluted EPS$-1.76
Shares outstanding103.7M

Ownership

103.7M shares outstanding · as of Aug 6, 2026
1.7%Insiders
Ownership
Insiders1.71%1,768,702
Institutions50.77%52,652,126
Public float47.52%49,283,981

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
de los Pinos ElisabetSee Remarks · Director
0.56%575,815
Hopkins Janet JillChief Medical Officer
0.31%321,340
Gibney Anthony SSee Remarks
0.27%278,178
Plavsic MarkChief Technology Officer
0.24%243,736
Kilroy ConorSee Remarks
0.22%229,573
Elazzouzi AmySenior Vice President, Finance
0.12%120,060

Institutional holders 122

View all →
HolderValue% of shares
Matrix Capital Management Company, LP$37.73M6.68%
BlackRock, Inc.$33.42M4.54%
Adage Capital Partners Gp, L.L.C.$32.65M4.71%
Frazier Life Sciences Management, L.P.$27.80M4.92%
Long Focus Capital Management, LLC$25.18M4.45%
Suvretta Capital Management, LLC$23.83M4.22%
Medicxi Ventures Management (Jersey) Ltd$16.57M2.93%
Vanguard Group Inc$16.00M2.83%
Franklin Resources, Inc.$11.98M2.12%
Nantahala Capital Management, LLC$11.54M2.04%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 17, 2026de los Pinos Elisabet
Executive
SellCommon Stock$241.1K-48K
-10.42%
409,815
0.40% of shares
medium
Feb 17, 2026Hopkins Janet Jill
Executive
SellCommon Stock$103.2K-20K
-8.07%
232,284
0.22% of shares
medium
Jan 20, 2026de los Pinos Elisabet
Executive
SellCommon Stock$82.3K-17K
-3.57%
457,463
0.44% of shares
low
Feb 17, 2026Plavsic Mark
Executive
SellCommon Stock$80.2K-16K
-8.05%
181,397
0.17% of shares
low
Feb 17, 2026Kilroy Conor
Executive
SellCommon Stock$61.0K-12K
-6.74%
167,234
0.16% of shares
low
Feb 17, 2026Elazzouzi Amy
Executive
SellCommon Stock$43.3K-9K
-10.17%
75,532
0.07% of shares
low
Jan 20, 2026Elazzouzi Amy
Executive
SellCommon Stock$7.7K-2K
-1.85%
84,081
0.08% of shares
low
Mar 2, 2026Kilroy Conor
Executive
GrantCommon Stock$0+62K
+37.28%
229,573
0.22% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Frazier Life Sciences Public Fund, L.P.Passive13G/A———
Advent Life Sciences LLPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AURACommon StockEquity05153U107BBG00226DGM5